Home
GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus
GSK today announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with systemic lupus erythematosus...
Press Releases
Expansion of Analytical Laboratories at Tredegar Center of Excellence for Contained Manufacturing
The Tredegar facility is our development and manufacturing Center of Excellence with specialist expertise in the processing of highly potent molecules. The site has...
Press Releases
Novartis Launches Two Joint Working Projects With NHS Cancer Vanguard Sites, Using Data Analysis to Improve Care Pathways for Cancer Patients
Novartis announced the launch of two new Joint Working Projects with National Cancer Vanguard sites, which aim to identify ways to improve cancer patient...
Press Releases
Novartis Launches Two Joint Working Projects With NHS Cancer Vanguard Sites, Using Data Analysis to Improve Care Pathways for Cancer Patients
Novartis announced the launch of two new Joint Working Projects with National Cancer Vanguard sites, which aim to identify ways to improve cancer patient...
Press Releases
Micell Technologies Announces Expanded Patent Estate
Micell® Technologies, Inc., a privately-held, development-stage biomedical company, today provided an update on its recently expanded intellectual property portfolio. With the granting of 24...
Press Releases
Invictus Opens TSX Venture Exchange Trading as GENE for the First Time
INVICTUS MD STRATEGIES CORP. is pleased to announce that , Gene Simmons, Chief Evangelist Officer for the company and its management team opened the...
Business & Industry
Lundbeck pharma acquires Prexton Therapeutics in EUR905m deal
Danish pharma company H. Lundbeck has agreed to acquire Switzerland-based Prexton Therapeutics, which develops drugs for Parkinson's disease and other brain disorders, in a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
